These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A computerized patient registration and treatment randomization system for multi-institutional clinical trials. Lange N; MacIntyre J Control Clin Trials; 1985 Mar; 6(1):38-50. PubMed ID: 3987302 [TBL] [Abstract][Full Text] [Related]
24. Automated weighing procedure for toxicological studies on small animals, using a minicomputer. Lewi PJ; Marsboom R Lab Anim Sci; 1975 Aug; 25(4):487-90. PubMed ID: 1152423 [TBL] [Abstract][Full Text] [Related]
25. The ethical approach to randomization in oncology. Arpaillange P; Dion S Drugs Exp Clin Res; 1986; 12(1-3):99-103. PubMed ID: 3732058 [No Abstract] [Full Text] [Related]
26. The case for randomization without consent in emergency care. Hallstrom A IRB; 1990; 12(4):5. PubMed ID: 11651262 [No Abstract] [Full Text] [Related]
27. Randomization for clinical research: an easy-to-use spreadsheet method. Padhye NS; Cron SG; Gusick GM; Hamlin SK; Hanneman SK Res Nurs Health; 2009 Oct; 32(5):561-6. PubMed ID: 19606450 [TBL] [Abstract][Full Text] [Related]
28. [The principle of randomization. An attempt at a medico-ethical analysis]. Ornskov F; Gøotzsche PC Ugeskr Laeger; 1988 Apr; 150(15):897-900. PubMed ID: 3363729 [No Abstract] [Full Text] [Related]
29. Permuted block design for randomization in a nursing clinical trial. Rudy EB; Vaska PL; Daly BJ; Happ MB; Shiao P Nurs Res; 1993; 42(5):287-9. PubMed ID: 8415043 [No Abstract] [Full Text] [Related]
30. [Randomization: apropos of controlled prospective studies in chemotherapy]. Charron C Soins; 1986 Aug; (483-484):18-20. PubMed ID: 3640551 [No Abstract] [Full Text] [Related]
33. [Medical and moral reasons for rejecting randomization in edematous diabetic retinopathy]. Haut J; Monin C; Abirached J; Larricart P Bull Soc Ophtalmol Fr; 1986; 86(8-9):1017-8. PubMed ID: 3568236 [No Abstract] [Full Text] [Related]
34. [Randomization and comparison of final quality in clinical studies]. Altman DG; Doré CJ Z Arztl Fortbild Qualitatssich; 2005; 99(10):629-34. PubMed ID: 16433266 [No Abstract] [Full Text] [Related]
35. The Kos statement on randomization. First International Meeting, Kos 1986; Second International Meeting, Paris 1987. Biomed Pharmacother; 1988; 42(3):167. PubMed ID: 3179401 [No Abstract] [Full Text] [Related]
36. Randomization and efficiency in Zelen's single-consent design. Matts J; McHugh R Biometrics; 1987 Dec; 43(4):885-94. PubMed ID: 3427173 [TBL] [Abstract][Full Text] [Related]
37. [Ethics of randomization]. Arpaillange P; Dion S Biomed Pharmacother; 1984; 38(9-10):426-9. PubMed ID: 6529599 [No Abstract] [Full Text] [Related]
38. Clinical trials: II. Randomization and sample size. Tilley B; Schork A Henry Ford Hosp Med J; 1985; 33(4):219-24. PubMed ID: 4086332 [No Abstract] [Full Text] [Related]
39. A treatment allocation procedure for sequential clinical trials. Begg CB; Iglewicz B Biometrics; 1980 Mar; 36(1):81-90. PubMed ID: 7370375 [TBL] [Abstract][Full Text] [Related]
40. Perspectives on clinical trials in the rheumatic diseases. Hart FD Clin Rheum Dis; 1983 Dec; 9(3):491-8. PubMed ID: 6606529 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]